Hege O. Ohnstad
Nydalen, 0424, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction: Lien et al. Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer. Cancers 2021, 13, 6118.
Journal: Cancers
Published: March 25, 2026
Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives.
Journal: Clinical breast cancer
Published: March 17, 2025
Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer-a prospective national multicentre study (EMIT-1).
Journal: ESMO open
Published: January 18, 2024
Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes.
Journal: Oncogenesis
Published: January 16, 2024
Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer.
Journal: Cancers
Published: October 30, 2021
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment.
Journal: Nature communications
Published: December 11, 2018
Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
Journal: Breast cancer research : BCR
Published: June 21, 2017
Response to preoperative chemotherapy in patients undergoing resection of pulmonary metastasis from soft tissue sarcoma - a predictor of outcome?
Journal: Acta oncologica (Stockholm, Sweden)
Published: April 05, 2014
Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma.
Journal: Cancer
Published: June 05, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026